April Clinical Policy Updates
04/16/2025
Effective May 16, 2025, the Meridian will be implementing the following clinical policies. Thank you for your continued partnership with Meridian.
Medical Policy | Policy Description |
|---|---|
CP.MP.164 | Caudal or Interlaminar Epidural Steroid Injections |
CP.MP.166 | Sacroiliac Joint Interventions for Pain Management |
CP.MP.167 | Intradiscal Steroid Injections for Pain Management |
CP.MP.169 | Trigger Point Injections for Pain Management |
CP.MP.171 | Facet Joint Interventions |
CP.MP.173 | Implantable Intrathecal or Epidural Pain Pump |
CP.MP.174 | Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy |
MI.CP.MP.165 | Selective Nerve Root Blocks and transformational Epidural Steroid Injections |
MI.CP.MP.170 | Nerve Blocks and Neurolysis for Pain Management |
CP.MP.93 | Bone Anchored Hearing Aid |
CP.MP.100 | Allergy Testing and Therapy |
CP.MP.155 | EEG in the Evaluation of Headache |
CP.MP.157 | 25-Hydroxyvitamin D Testing in Children and Adolescents |
CP.MP.184 | Home Ventilators |
A complete list of our clinical policies can be found on the Clinical and Payment Policies page.